This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations by Katalin Dubovszki in Chemical Synthesis
Introduction
Katalin Dubovszki is a notable inventor based in Budapest, Hungary, recognized for her contributions in the field of chemistry. With two patents to her name, she plays a significant role in advancing the synthesis of pharmaceutical compounds, particularly those useful in treating conditions related to angiotensin II.
Latest Patents
Katalin Dubovszki's most recent patents focus on innovative processes for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates. The detailed processes involve reacting specific compounds to create valuable intermediates that are crucial for synthesizing angiotensin II antagonists. The methodologies outlined in her patents describe various reaction conditions, including the requirement for a reaction medium with a pH above 7 and the transformation of compounds into acid addition salts.
Career Highlights
Katalin's affiliation with Sanofi-Synthelabo showcases her commitment to pharmaceutical innovation. At Sanofi-Synthelabo, she has become an integral part of a team that strives to develop new medications. Her expertise not only contributes to her patents but also enhances the organization's research capabilities.
Collaborations
Throughout her career, Katalin has collaborated with esteemed colleagues such as Attila Kis-Tamás and Csaba Huszár. These partnerships highlight the collaborative nature of scientific research, where teamwork is essential in driving advancements and bringing innovative solutions to life.
Conclusion
Katalin Dubovszki stands as a prominent figure in the realm of chemical synthesis and pharmaceutical innovation. Through her patents and collaborative efforts at Sanofi-Synthelabo, she continues to push the boundaries of medical chemistry, contributing significantly to the field and enhancing therapeutic options for patients. As her work progresses, the impact of her inventions is poised to grow, marking her as a key inventor to watch in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile